About Solarea Bio
Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
Website: Learn more on Solarea Bio’s website
Crunchbase: Follow on Crunchbase
[adace-ad id=”4426″]Series A – Solarea Bio
| Amount Raised | 11200000 USD |
| Announced Date | 2020-10-19 |
| Equity Only Funding | Yes |
| Organization Location | Cambridge, Massachusetts, United States, North America |
| Funding Status | Early Stage Venture |
| Number of Funding Rounds | 2 |
| Lead Investors | Bold Capital Partners, S2G Ventures |
| Number of Investors | 4 |
| Number of Partner Investors | 2 |
